Pricing Log in Create free account

Eiger BioPharmaceuticals, Inc. (EIGRQ) vs Silexion Therapeutics Corp (SLXN)

Eiger BioPharmaceuticals, Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Eiger BioPharmaceuticals, Inc. and Silexion Therapeutics Corp are of similar size ($2.7M and $2.6M). Silexion Therapeutics Corp has the higher net margin (0.00% vs −475.3%) and the higher return on invested capital (0.00% vs −3,674.6%). Across the 12 metrics below, Eiger BioPharmaceuticals, Inc. leads on 6 and Silexion Therapeutics Corp on 6.

Valuation

Metric EIGRQ SLXN Biotechnology median
P/E n/m n/m 8.50
P/S 0.80 n/m 9.71
P/B n/m 2.34 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.04 0.64
EV/Sales 4.37 n/m 9.21
Earnings yield (601.00%) (14,489.87%) (33.15%)
Free cash flow yield (594.47%) (12,070.84%) (25.50%)

Profitability

Metric EIGRQ SLXN Biotechnology median
Gross margin 99.85% — 65.16%
Operating margin (455.12%) 0.00% 0.00%
Net margin (475.26%) 0.00% 0.00%
Free cash flow margin (474.11%) 0.00% 0.00%
Return on equity (367.00%) (17,021.95%) (56.36%)
Return on assets (94.31%) (277.96%) (48.04%)
Return on invested capital (3,674.55%) 0.00% 0.00%

Growth

Metric EIGRQ SLXN Biotechnology median
Revenue growth (TTM) 16.98% — 6.02%
EPS growth (last fiscal year) 27.11% 97.73% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EIGRQ SLXN Biotechnology median
Debt to equity (2.84) 0.00 0.00
Current ratio 0.71 0.94 4.72
Net debt to EBITDA (0.22) 0.38 0.96

Dividend

Metric EIGRQ SLXN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EIGRQ SLXN Biotechnology median
Market cap 2.55m 2.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack